5.0/5
G2 rating
21 verified reviews
Report
Legislative and bill tracking software for all 50 states, federal, and regulatory. Track every bill and hearing live, search every word said, brief in minutes.
Depends
DependsBuy if you're a lobbying or government affairs team that needs live multi-state hearing intelligence with transcripts and AI search.
Powerful AI bill tracking across 50 states at $250–499/seat/mo — great for GR teams, overkill for casual single-state trackers.
5.0/5
G2 rating
21 verified reviews
$250/mo
Starting price
per seat, published
2023
AI-native since
founded by lobbyist, operator, engineer
$2.7M
Funding
raised May 2025, venture-backed
Published pricing undercuts quote-only incumbents
30-minute migration claims; briefs in minutes
50 states, hearings, transcripts, search, AI summaries
Direct human support email; responsive testimonials
SOC 2 Type II, TX-RAMP, no-training policy
$250–$499/mo
No known public vulnerabilities found in the sources reviewed.
All 21 G2 reviews are five stars, and vendor-published testimonials praise real-time transcripts and AI summaries turning hours of work into minutes.
“USLege changed the way I work by simplifying many of the tasks we have as gover”
“USLege is truly a blessing! The capabilities to read transcripts in real time”
“USLege's live transcripts and AI summaries turned that into minutes, and the firm turne”
Compare USLege.ai with each alternative.
Guess: incumbent gov-affairs suite with broader engagement tools beyond tracking.
USLege.ai vs QuorumGuess: established monitoring giant; deeper archives, older experience.
USLege.ai vs LexisNexis State NetGuess: free bill tracking for budget-conscious single-state watchers.
USLege.ai vs OpenStatesBased on ~30 public sources; independent reviews limited to 21 G2 ratings, most testimonials vendor-published.
Anonymous. You can change your vote.
Loading votes…
Ask if a use case fits. Answers stay inside this report and its sources.
Comments
One queue. No replies. Give a display name first. Limit: 7 comments per day.
No comments yet.